Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa — RePAN  

Anorexia Nervosa Clinical Trial

Official title: Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa: A Randomized Control Trial

Status Completed

Clinical Trial Summary

Anorexia Nervosa inpatient treatment has often a short-term success as weight is restored to a healthy level, but high percentage of patients relapse during the first year following the discharge. The development of strategies to overcome this problem represents a priority for clinicians. Aim of this trial is to evaluate the effects of a relapse prevention program based on cognitive dissonance theory developed for hospitalized patients.

Clinical Trial Description

Inpatient treatment for anorexia nervosa is often successful in restoring body weight, but a high percentage of patients relapse following discharge. The aim of the study was to assess the effect of a relapse prevention program during the last phase of inpatient treatment. Patients, when they achieve a BMI of 18.5, are randomly allocated to complete the standard cognitive behavior inpatient treatment (CBT-I) or to complete the standard CBT-I plus eight relapse prevention groups based on the cognitive dissonance. The intervention has been derived by the selective and indicated prevention programs using a dissonance-based approach. This intervention showed to be effective in reducing the risk for eating pathology onset. The primary outcome of the study is to assess the number of patients allocated to the two condition with a BMI equal or greater than 18.5 at 12-months after discharge. ;

Related Conditions & MeSH terms

• Anorexia
• Anorexia Nervosa
• Recurrence

• NCT number: NCT01611220
• Study type: Interventional
• Source: Villa Garda Hospital
• Status: Completed
• Phase: N/A
• Start date: June 2012
• Completion date: October 2018